Summit Therapeutics Inc.

NASDAQ: SMMT · Real-Time Price · USD
26.67
0.22 (0.83%)
At close: Aug 15, 2025, 3:59 PM
26.50
-0.64%
After-hours: Aug 15, 2025, 07:37 PM EDT

Summit Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-565.71M -62.91M -61.2M -56.25M -60.38M -43.47M -36.57M -21.27M -14.72M -542.38M -19.23M -21.39M -16.77M -21.4M -27.1M -19.6M -24.42M -17.49M
Depreciation & Amortization
-986K -2.94M 22K 20K 20K 27K 605K 599K 471K 90K 596K 712K 591K 615K 671K 632K 665K 487K
Stock-Based Compensation
478.78M 11.1M 11.02M 19.37M 11.09M 7.53M 6.87M 577.86K 1.48M 2.77M 2.2M 2.51M 2.5M 4M 5.62M 2.64M 3.67M 868K
Other Working Capital
n/a -6.54M -2.28M 8.86M 6.17M -92K 8.99M 1.11M -13.9M -1.69M 15.95M 7.32M -1.47M -6.18M 11.07M -5.87M -1.7M -724K
Other Non-Cash Items
21.17M -224K 2.44M -2.55M 27.76M 10.62M 82K -63K 111K 526.56M 9M 1.82M 743K 198K 987K 1.02M 436K -1.62M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -648K 1.69M -3.42M n/a n/a n/a n/a 1.04M 970K 851K 224K -1.72M
Change in Working Capital
n/a -6.19M -950.95K 8.96M 2.99M 4.2M 8.32M 3.44M -13.6M -183K 12.17M 7.5M -7.61M -3.45M 10.64M -8.26M 469K -2.92M
Operating Cash Flow
-66.74M -61.17M -48.67M -30.45M -32.85M -30.13M -19.46M -14.9M -29.27M -13.13M 5.19M -8.55M -19.22M -19M -9.18M -23.57M -19.17M -20.67M
Capital Expenditures
n/a -422K -14.16K -58K -62.84K -4K -2K -53K -20K -53K 994.38K 20K -293K -361K -120K 4K -151K -39K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a -4.86K 993.19 229.42K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a -149.49M -168.42M -269.14M -92.98M 1K -112.86M -38.17M -170M n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
150.81M 160.53M 232.98M 74.44M 69.56M 112.86M 60.57M 109.42M 38.75M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a 162.00 -14.57M n/a 15.69M 4.86K -993.19 -581.6K -475.01M -984.38K n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
150.81M 160.11M 83.48M -108.61M -199.64M 19.87M 60.57M -3.49M 207K -645.06M 10K 20K -293K -361K -120K 4K -151K -39K
Debt Repayment
n/a n/a -24.5M -75.5M n/a n/a n/a n/a -373.92K -24.69M 520M -25M -808.01K 25M n/a n/a -55M 55M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
2.22M n/a 7.81M 1.64M 483.68K 485K 6.25M 229K 293.92K 104.8M 60K 100M -0.05 187K 1.26M 676K 75.08M 897K
Financial Cash Flow
2.22M 7.68M -23.61M 204.14M 199.73M 485K 6.25M 229K -80K 80.11M 520.06M 75M -814.06K 25.19M 1.26M 676K 20.08M 55.9M
Net Cash Flow
86.35M 106.66M 11.09M 65.34M -32.86M -9.81M 47.63M -18.32M -28.85M -577.64M 526.64M 64.64M -20.11M 5.66M -8.46M -23.14M 1.19M 35.78M
Free Cash Flow
-66.74M -61.59M -48.69M -30.36M -32.91M -30.14M -19.46M -14.95M -29.29M -13.18M 6.19M -8.54M -19.51M -19.36M -9.3M -23.56M -19.32M -20.71M